Procedural safety and short-term outcome of percutaneous LAA occlusion
| Reference | Patients (n) | Successful implantation (%) | Pericardial effusion (%) | Device embolisation (%) | Bail-out surgery (%) | Stroke/ embolism (%) | Major bleeding (%) | Death |
|---|---|---|---|---|---|---|---|---|
| PLAATO | ||||||||
| Sievert et al75 | 15 | 100 | 6.7 | 0 | 0 | 0 | 0 | 0 |
| Hanna et al76 | 11 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ostermayer et al77 | 111 | 97 | 4.6 | 0 | 0.9 | 0 | – | 0.9 |
| El-Chami et al78 | 11 | 100 | 0 | 0 | 0 | 0 | – | 0 |
| De Meester (2008)79 | 10 | 90 | 0 | 11.1 | 0 | 0 | – | 0 |
| Ussia et al80 | 20 | 90 | 5.6 | 0 | 0 | 0 | 0 | 0 |
| Park et al81 | 73 | 100 | 1.4 | 1.4 | 1.4 | 1.4 | – | 1.4 |
| Block et al82 | 64 | 98 | 1.6 | – | 1.6 | – | – | 1.6 |
| Bayard et al83 | 180 | 90 | 3.3 | 0.6 | 1.1 | – | – | 1.1 |
| Viles-Gonzalez et al64 | 22 | 100 | 4.5 | 0 | 0 | 0 | – | 0 |
| Watchman | ||||||||
| Sick et al84 | 66 | 88 | 3.0 | 3 | 1.5 | 0 | 1.5 | 0 |
| Holmes et al55 | 463 (PAF) | 88 | 4.8 | 0.6 | 1.9 | 0.2 | – | 0 |
| Reddy et al60 | 460 (CAP) | 95 | 2.2 | 0 | 0.2 | 0 | 0.7 | 0 |
| Kim et al85 | 5 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Swaans et al86 | 10 | 100 | 0 | 10.0 | 0 | 0 | 10.0 | 0 |
| Bai et al87 | 58 | 100 | 1.7 | 0 | 0 | 0 | 0 | 0 |
| Swaans et al88 | 30 | 100 | 0 | 3.3 | 0 | 0 | 0 | 0 |
| Reddy et al56 | 150 | 95 | 1.3 | 1.3 | – | 0 | – | 0 |
| ACP | ||||||||
| Park et al89 | 137 | 96 | 3.6 | 1.5 | – | 2.2 | 0 | 0 |
| Lam et al90 | 20 | 95 | 0 | 0 | 0 | – | 0 | 0 |
| Montenegro et al91 | 5 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Danna et al92 | 37 | 92 | 2.9 | 5.9 | 0 | 0 | – | 0 |
| López-Mínguez et al72 | 35 | 97 | 0 | 0 | 0 | 0 | 0 | 0 |
| Helsen et al93 | 15 | 100 | 0 | 0 | 0 | 6.7 | 0 | 0 |
| Nietlispach et al94* | 152 | 96 | 2.6 | 4.6 | 3.3 | 2.0 | – | 0 |
| Freixa et al33 | 42 | 100 | 0 | 0 | 0 | 0 | 0 | 0 |
| Urena et al95 | 52 | 98 | 1.9 | 1.9 | 0 | 0 | 3.8 | 0 |
| Streb et al96 | 21 | 95 | 4.8 | 0 | 0 | 0 | 0 | 0 |
| Meerkin et al97 | 100 | 100 | 1.0 | 0 | 0 | 0 | 0 | 0 |
| Faustino et al98 | 21 | 96 | 0 | 0 | 0 | 0 | 0 | 0 |
| Plicht et al57 | 34 | 100 | 2.9 | 0 | 0 | 0 | 5.9 | 0 |
| Apostolos et al62 | 969 | 97 | 1.2 | 0.2 | – | 0.7 | 1.2 | 0.6 |
*Nietlispach et al94: non-dedicated LAA occlusion devices were used in 32 patients, dedicated (ACP) in 120 patients.
ACP, Amplatzer cardiac plugs; LAA, left atrial appendage.